Sunshine Biopharma Inc.
SBFM· Nasdaq
SBFMSunshine Biopharma Inc.
Filed Apr 12, 2019 · 10-K · 102 days after period end · 0001654954-19-004354
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 |
| Net Income | -$338.66K | -$211.48K | -$1.12M | -$638.21K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Apr 12, 2019 · 102 d after period end
